Bisoprololo Winthrop

Bisoprololo Winthrop may be available in the countries listed below.

Ingredient matches for Bisoprololo Winthrop

Bisoprolol

Bisoprolol fumarate (a derivative of Bisoprolol) is reported as an ingredient of Bisoprololo Winthrop in the following countries:

• Italy

International Drug Name Search

Artelac Advanced EDO

Artelac Advanced EDO may be available in the countries listed below.

Ingredient matches for Artelac Advanced EDO

Hyaluronic Acid

Hyaluronic Acid is reported as an ingredient of Artelac Advanced EDO in the following countries:

• Germany

International Drug Name Search

Teniverm

Teniverm may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Teniverm

Levamisole

Levamisole hydrochloride (a derivative of Levamisole) is reported as an ingredient of Teniverm in the following countries:

• France

Niclosamide

Niclosamide is reported as an ingredient of Teniverm in the following countries:

• France


• Portugal

Tetramisole

Tetramisole hydrochloride (a derivative of Tetramisole) is reported as an ingredient of Teniverm in the following countries:

• Portugal

International Drug Name Search

Celestoderm

Celestoderm may be available in the countries listed below.

Ingredient matches for Celestoderm

Betamethasone

Betamethasone is reported as an ingredient of Celestoderm in the following countries:

• Latvia

Betamethasone 17α-valerate (a derivative of Betamethasone) is reported as an ingredient of Celestoderm in the following countries:

• Bahrain


• Colombia


• Estonia


• Finland


• Georgia


• Switzerland


• Venezuela

International Drug Name Search

Kuterid

Kuterid may be available in the countries listed below.

Ingredient matches for Kuterid

Betamethasone

Betamethasone 17α,21-dipropionate (a derivative of Betamethasone) is reported as an ingredient of Kuterid in the following countries:

• Bosnia & Herzegowina


• Croatia (Hrvatska)


• Czech Republic


• Poland


• Slovakia


• Slovenia

International Drug Name Search

Zoladex

Zoladex is a brand name of goserelin, approved by the FDA in the following formulation(s):

ZOLADEX (goserelin acetate - implant; implantation)

• 
  Manufacturer: ASTRAZENECA
  
  Approval date: December 29, 1989
  
  Strength(s): EQ 3.6MG BASE ^[RLD]


• 
  Manufacturer: ASTRAZENECA
  
  Approval date: January 11, 1996
  
  Strength(s): EQ 10.8MG BASE ^[RLD]

Has a generic version of Zoladex been approved?

No. There is currently no therapeutically equivalent version of Zoladex available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Zoladex. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Automatically operable safety shield system for syringes
  Patent 7,118,552
  Issued: October 10, 2006
  Inventor(s): Shaw; Derek J. & Law; Brian R.
  Assignee(s): AstraZeneca AB
  An automatically operable safety shield system for use with a syringe, the safety shield system including an holder having proximal and distal portions and defining an enclosure into which the syringe may be inserted, an outer shield having proximal and distal portions, mounted outwards from the inner holder being axially movable relative to the inner holder between retracted and extended positions, a spring positioned between a first detent on the inner holder and a second detent on the outer shield, and urging the outer shield to its extended position, the inner holder having at least one first opening and the outer shield having at least one first stop member, the first stop member being engageable with the first opening when the outer shield is in the retracted position, the inner holder having distal to the first opening at least one first indentation, the first stop member being engageable with the first indentation when the outer shield is in the extended position.
  
  Patent expiration dates:
  
  
  • April 13, 2022
    
    ✓ 
    Drug product
  
  



• 
  Automatically operable safety shield system for syringes
  Patent 7,220,247
  Issued: May 22, 2007
  Inventor(s): Shaw; Derek J & Law; Brian R
  Assignee(s): AstraZeneca AB
  An automatically operable safety shield system for use with a syringe that comprises an inner holder in which said syringe may be inserted and an outer shield mounted outwards from the inner holder axially movable between retracted and extended positions in which a spring positioned between said inner holder and said outer shield urging the outer shield to its extended position and the inner holder having at least one first opening, distally thereto, at least one first indentation, and the outer shield having at least one first stop member engageable with the opening when the outer shield is in the retracted position engageable with the first indentation when the outer shield is in the extended position and the outer shield may be released from its retracted position by action of a trigger positioned within the inner holder or by protrusion on the syringe plunger.
  
  Patent expiration dates:
  
  
  • April 9, 2022
    
    ✓ 
    Drug product
  
  



• 
  Automatically operable safety shield system for syringes
  Patent 7,500,964
  Issued: March 10, 2009
  Inventor(s): Shaw; Derek J. & Law; Brian R.
  Assignee(s): AstraZeneca AB
  An automatically operable safety shield system for use with a syringe that comprises an inner holder in which said syringe may be inserted and an outer shield mounted outwards from the inner holder axially movable between retracted and extended positions in which a spring positioned between said inner holder and said outer shield urging the outer shield to its extended position and the inner holder having at least one first opening, distally thereto, at least one first indentation, and the outer shield having at least one first stop member engageable with the opening when the outer shield is in the retracted position engageable with the first indentation when the outer shield is in the extended position and the outer shield may be released from its retracted position by action of a trigger positioned within the inner holder or by protrusion on the syringe plunger.
  
  Patent expiration dates:
  
  
  • February 26, 2021
    
    ✓ 
    Drug product
  
  

See also...

• Zoladex Consumer Information (Drugs.com)
• Zoladex Consumer Information (Wolters Kluwer)
• Zoladex Consumer Information (Cerner Multum)
• Zoladex Advanced Consumer Information (Micromedex)
• Zoladex AHFS DI Monographs (ASHP)
• Goserelin Consumer Information (Wolters Kluwer)
• Goserelin Consumer Information (Cerner Multum)
• Goserelin Subcutaneous Advanced Consumer Information (Micromedex)
• Goserelin Acetate AHFS DI Monographs (ASHP)

Kefurox

In the US, Kefurox is a member of the drug class second generation cephalosporins and is used to treat Bacterial Infection, Bladder Infection, Bone infection, Bronchitis, Epiglottitis, Gonococcal Infection - Disseminated, Gonococcal Infection - Uncomplicated, Impetigo, Joint Infection, Kidney Infections, Lyme Disease, Meningitis, Otitis Media, Peritonitis, Pneumonia, Sepsis, Sinusitis, Skin and Structure Infection, Skin Infection, Strep Throat, Surgical Prophylaxis, Tonsillitis/Pharyngitis, Upper Respiratory Tract Infection and Urinary Tract Infection.

Ingredient matches for Kefurox

Cefuroxime

Cefuroxime sodium salt (a derivative of Cefuroxime) is reported as an ingredient of Kefurox in the following countries:

• Belgium


• Kenya


• Luxembourg


• Tanzania


• Uganda

International Drug Name Search

Isopal P

Isopal P may be available in the countries listed below.

Ingredient matches for Isopal P

Isoprenaline

Isoprenaline hydrochloride (a derivative of Isoprenaline) is reported as an ingredient of Isopal P in the following countries:

• Japan

Pronase

Pronase is reported as an ingredient of Isopal P in the following countries:

• Japan

International Drug Name Search

Atenololo Alter

Atenololo Alter may be available in the countries listed below.

Ingredient matches for Atenololo Alter

Atenolol

Atenolol is reported as an ingredient of Atenololo Alter in the following countries:

• Italy

International Drug Name Search

Medetomidine

In some countries, this medicine may only be approved for veterinary use.

Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0086347-14-0

Chemical Formula

C13-H16-N2

Molecular Weight

200

Therapeutic Categories

Sedative agent

Analgesic

Muscle relaxant

α2-adrenoceptor agonist

Chemical Name

1H-Imidazole, 4-[1-(2,3-dimethylphenyl)ethyl]-, (±)-

Foreign Names

• Medetomidinum (Latin)
• Medetomidin (German)
• Medetomidine (French)
• Medetomidina (Spanish)

Generic Names

• Medetomidine (OS: BAN)
• MPV 295 (IS: FarmosGroupLt)
• Medetomidine Hydrochloride (OS: USAN)

Brand Names

• Cepetor (veterinary use)
  ScanVet, Sweden



• Domitor (veterinary use)
  Orion, United States; Pfizer Animal Health, New Zealand



• Cepetor (veterinary use)
  Botéba, Netherlands; CP, Netherlands; CP-Pharma, Germany; CP-Pharma, Poland; Scanvet, Finland



• Domitor (veterinary use)
  Botéba, Netherlands; Orion, Finland; Orion, Poland; Orion, Sweden; Orion Animal Health, Norway; Pfizer, Austria; Pfizer Animal, Portugal; Pfizer Animal Health, Australia; Pfizer Animal Health, Belgium; Pfizer Animal Health, Switzerland; Pfizer Animal Health, United Kingdom; Pfizer Animal Health, Italy; Pfizer Animal Health, Luxembourg; Pfizer Animal Health, Netherlands; Pfizer Animal Health, South Africa; Pfizer Consumer Healthcare, Ireland; Pfizer GmbH Tiergesundheit, Germany; Pfizer Santé Animale, France



• Dorbene Vet (veterinary use)
  Fort Dodge Santé Animale, France



• Dorbene (veterinary use)
  Fort Dodge, Germany; Gräub, Switzerland; Vetcare, Finland



• Medetor (veterinary use)
  Virbac, Switzerland; Virbac, France



• Sedamed (veterinary use)
  Nature Vet, Australia; Vetpharm, New Zealand



• Sedator (veterinary use)
  Albrecht, Germany; Eurovet, Austria; Eurovet, Belgium; Eurovet, Netherlands; Sogeval, France

International Drug Name Search

Glossary

BAN	British Approved Name
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.